tiprankstipranks
Trending News
More News >
Calian Group Ltd. (TSE:CGY)
TSX:CGY

Calian Group (CGY) AI Stock Analysis

Compare
159 Followers

Top Page

TSE:CGY

Calian Group

(TSX:CGY)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
C$91.00
▲(17.81% Upside)
Action:DowngradedDate:02/18/26
Overall score reflects solid but not standout financial quality (slower TTM growth, thin net margins, and higher leverage) offset by strong technical momentum and a positive earnings call with reaffirmed double-digit growth and margin-improvement targets. Valuation is a headwind due to a higher P/E and modest yield.
Positive Factors
Large Backlog and New Signings
A $1.4B backlog and meaningful quarterly new signings provide durable revenue visibility across multi-year contracts. This reduces short-term revenue volatility, supports predictable cash flow realization, and underpins medium-term planning for staffing, capex and cross-sell initiatives.
Strength in Defense & Space
Material wins in mission‑critical Defense & Space position the company in high-barrier, long-term markets where technical expertise and reliability matter. Such contracts often yield repeatable revenue, higher customer stickiness and favorable margin mix versus commoditized services.
Positive Cash Generation and Liquidity
Consistent free cash flow growth and ample available liquidity support organic investment, M&A execution and the dividend policy. A net debt/EBITDA around 1.2x provides financial flexibility to pursue accretive acquisitions while maintaining investment in operations and margin improvement plans.
Negative Factors
Rising Leverage Over Time
A material increase in total debt over several years reduces financial resilience. Higher leverage magnifies downside risk if revenue or margins weaken, constrains discretionary investment, and increases sensitivity to interest-cost fluctuations and acquisition-related earnouts.
Thin Bottom‑Line Margins
Low net margins limit retained earnings and the capacity to absorb cost shocks or fund growth from operating profits. With revenue growth slowed to low single digits, margin compression or adverse mix shifts could materially erode profitability and free cash flow over the medium term.
Working‑Capital and Acquisition Cash Strain
Acquisition-driven working capital increases and recent debt draws highlight cash conversion volatility. Ongoing earn‑out obligations and integration costs may pressure near‑term cash flow and require continued leverage or deferred shareholder returns, affecting medium‑term financial flexibility.

Calian Group (CGY) vs. iShares MSCI Canada ETF (EWC)

Calian Group Business Overview & Revenue Model

Company DescriptionCalian Group Ltd. provides business services and solutions in the areas of health, defense, security, aerospace, engineering, AgTech, and information technology (IT) in Canada, the United States, and Europe. The company's Advanced Technologies segment offers developed products and engineering solutions for the space, communications, nuclear, agriculture, defense, automotive, and government sectors; software and product development, custom manufacturing, full life-cycle support, studies, requirements analysis, project management, multi-discipline engineered system solutions, and training services; communication systems and products for terrestrial and satellite networks; satellite gateways comprising aperture radio frequency antennas, and telemetry tracking and control, as well as software solutions for managing and monitoring networks; engineering and technical services for propulsion, electrical and electronic systems, computer and nuclear systems, naval architecture, and aerospace; and nuclear services to develop waste management and decommissioning solutions. Its Health segment offers primary care and occupational health services; and clinic management, healthcare practitioner support, and psychological assessment services. The company's Learning segment provides training services and solutions; and consulting services in emergency management, training, and advanced training technologies, as well as Calian MaestroEDE, a tool for collective training exercises for military customers; and Calian ResponseReady, an online platform and simulation tool for emergency management training exercise delivery and evaluation. Its IT segment provides cloud migration, IT development, SAP consulting, and cyber security solutions, as well as IT support services. The company was formerly known as Calian Technologies Ltd. and changed its name to Calian Group Ltd. in April 2016. The company was incorporated in 1982 and is headquartered in Ottawa, Canada.
How the Company Makes MoneyCalian generates revenue through a diverse array of streams. Primarily, the company earns income from its professional services divisions, which include healthcare staffing and IT support services. The healthcare division provides personnel to hospitals and clinics, while the IT sector offers cybersecurity and technology solutions to both public and private entities. Additionally, Calian's engineering and training services contribute significantly to its revenue, with contracts often awarded by government agencies and large corporations. Strategic partnerships with both public sector clients and private industry players also enhance its market reach and profitability. The company's ability to secure long-term contracts and maintain a robust pipeline of projects is crucial for sustaining its earnings.

Calian Group Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:May 19, 2026
Earnings Call Sentiment Positive
The call conveyed a largely positive tone: strong, record Q1 financial results (12% revenue growth, 28% adjusted EBITDA growth), improved margins and cash generation, meaningful backlog and notable Defense & Space contract wins. Acquisitions are accelerating growth and management reaffirmed midterm targets (10–15% revenue growth, adjusted EBITDA outpacing revenue). Key risks noted were timing uncertainty around Canadian defense opportunities, temporary working capital and debt draws to fund acquisitions, some one‑time offsets to EBITDA and a pause of the buyback program. Overall, the favorable operating and financial momentum and manageable balance sheet profile outweigh these near‑term uncertainties.
Q1-2026 Updates
Positive Updates
Record Q1 Revenue and Organic Growth
Revenue reached $208 million, a record for a first quarter, up 12% year‑over‑year. Organic growth was 6%, marking the second consecutive quarter of positive organic growth and signaling stabilization after prior headwinds.
Strong Adjusted EBITDA and Margin Expansion
Adjusted EBITDA rose to $23 million, up 28% YoY, driving adjusted EBITDA margin to 11% from 9.6% a year ago. Management expects margins to improve further and to exit the year at double‑digit levels.
Improved Gross Profit and Gross Margin
Gross profit increased to $71 million, up 21% from $59 million a year earlier. Gross margin expanded to 34.1% from 31.8%, driven by revenue growth, mix improvements and contributions from acquisitions.
Robust Backlog and New Signings
The company concluded the quarter with $171 million in new signings and a backlog of $1.4 billion, providing a strong foundation for future revenue visibility.
Material Defense & Space Wins
Renewed momentum in Defense and Space highlighted by two antenna contracts totaling >$35 million, a >$30 million ground‑station contract with a leading global space company, and a German Federal Ministry of Defense QV‑band antenna win—underscoring strength in mission‑critical infrastructure.
Essential Industries Growth and AMS Contribution
Essential Industries revenue increased nearly 20% in the quarter, driven largely by the AMS acquisition and a rebound in U.S. commercial operations; the acquisition materially strengthened Arctic and energy/health footprints.
Healthy Cash Generation and Leverage Profile
Operating free cash flow rose 21% to $16 million, with cash conversion at 69% of adjusted EBITDA. Cash flow from operations was $7 million (vs. $4 million prior year). Net debt was $102 million with net debt/adjusted EBITDA of 1.2x, comfortably below the 2.5x threshold; total liquidity (unused facility + cash + accordion) ~ $250 million.
Disciplined Capital Deployment and M&A Momentum
Acquisitions contributed 6% to revenue growth (AMS, Infield Scientific, Info Scientific). Management prioritized M&A as primary capital deployment, funded acquisition activity ($18M acquisition‑related payments this quarter) while maintaining dividend policy (returned $3M) and keeping buybacks paused to prioritize strategic transactions.
Simplified Operating Structure
Company reorganized from four segments to two (Defense & Space ~2/3 of revenue; Essential Industries ~1/3), intended to sharpen focus, improve capital/talent deployment and increase transparency—management expects this to support faster integrated solution delivery and margin improvement.
Negative Updates
Timing Uncertainty in Canadian Defense Opportunity
Management noted that while the direction in Canadian defense spending is positive, the precise timing of opportunities remains difficult to predict, creating near‑term visibility risk for related revenue streams.
Working Capital Impact from Acquisitions
Working capital efficiency moved to ~10% from 8.5% last year, reflecting working capital acquired through recent acquisitions and a seasonal first‑quarter use of working capital that the company expects to reverse in later quarters.
Increased Debt Draw to Fund Acquisitions
The company drew an additional $34 million on its debt facility in Q1 to fund acquisitions and earnouts; while leverage remains modest (net debt/EBITDA 1.2x), debt increased during the quarter and future earn‑out obligations remain (AMS ~$5M expected in Q2 and residual HCT earn‑out over coming quarters).
One‑time Items and Reclassification Effects
Adjusted EBITDA growth was partially offset by a few one‑time items. Additionally, a change in shared services expense allocation (reclassification under the new structure) increased reported shared services in fiscal 2025 compared with prior presentation, complicating YoY expense comparability.
Pause of Share Repurchase Program
The company temporarily paused its share repurchase program and redirected capital to higher priority strategic initiatives; while fiscally prudent, this may be viewed negatively by investors seeking buyback‑driven returns in the near term.
Seasonality and Near‑term Delivery Mismatch
Management indicated some contract signings (e.g., cybersecurity and backlog wins) did not convert into revenue this quarter and will contribute in coming quarters; coupled with hardware delivery seasonality, this creates short‑term revenue timing variability.
Company Guidance
Management reiterated an unchanged fiscal 2026 outlook, targeting 10–15% annual revenue growth over the next several years (consistent with a ~12% historical CAGR) and saying adjusted EBITDA growth should consistently outpace revenue in the mid‑term; for fiscal '26 they expect double‑digit growth in both revenue and adjusted EBITDA versus fiscal '25 and to exit the year with double‑digit margins. They expect about $10M of capital expenditures, working‑capital usage to track with revenue growth, and maintain a dividend policy targeting a 25–30% payout of operating free cash flow; M&A remains the top capital priority (including ~ $5M AMS earn‑out in Q2 and remaining HPT earn‑out payments over the coming quarters). Balance‑sheet guidance/metrics noted net debt of $102M (net‑debt/adjusted EBITDA of 1.2x, well below a 2.5x threshold) and roughly $250M of available liquidity, while Q1 operational metrics called out $7M of cash from operations, $16M of operating free cash flow and ~69% cash conversion of adjusted EBITDA.

Calian Group Financial Statement Overview

Summary
Stable profitability and positive cash generation, but TTM growth has slowed to low single digits and net margin remains thin (~2.7%). Leverage has risen materially (debt up to ~206M; D/E ~0.54), and cash-flow conversion/consistency is a watch item despite positive FCF.
Income Statement
64
Positive
TTM (Trailing-Twelve-Months) revenue is ~797M with low-single-digit growth, marking a clear slowdown versus the strong double-digit growth seen in 2021–2024. Profitability is steady at the gross level (mid-30% range), but the business runs on thin bottom-line margins (TTM net margin ~2.7%). EBIT and EBITDA margins are moderate for the space (~4.4% and ~10.4%), supporting consistent earnings power, but overall profit conversion remains a key limitation.
Balance Sheet
58
Neutral
The balance sheet is still supported by a solid equity base (~322M) versus total assets (~751M), but leverage has risen meaningfully over time: total debt increased from ~27M (2022) to ~206M (TTM), with debt-to-equity now ~0.54 (up from ~0.09 in 2022). Returns on equity are positive and improving versus 2024 (~6.5% TTM vs ~3.4% in 2024), but the higher debt load reduces financial flexibility if operating conditions soften.
Cash Flow
55
Neutral
Cash generation is positive (TTM operating cash flow ~48M; free cash flow ~37M), and free cash flow growth is positive in TTM, but cash flow has been volatile year-to-year (notably higher in 2024 vs lower in 2025). Free cash flow is below net income in the latest period (about 77% of net income), suggesting less efficient cash conversion than ideal. Overall, the company produces cash, but consistency and conversion are the main watch items.
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Income Statement
Total Revenue797.06M774.11M746.61M658.58M582.17M518.40M
Gross Profit271.39M259.29M254.01M204.21M169.23M126.74M
EBITDA87.46M80.79M70.78M59.27M56.06M37.59M
Net Income26.63M20.56M11.18M18.89M13.60M11.15M
Balance Sheet
Total Assets750.51M721.50M707.92M585.72M547.16M457.97M
Cash, Cash Equivalents and Short-Term Investments62.64M46.10M51.79M33.73M42.65M78.61M
Total Debt206.39M174.20M129.19M74.76M26.54M17.48M
Total Liabilities428.52M400.22M381.17M257.35M241.98M165.61M
Stockholders Equity321.99M321.28M326.75M328.37M305.19M292.36M
Cash Flow
Free Cash Flow36.73M34.84M75.42M48.34M35.82M38.69M
Operating Cash Flow48.22M45.43M87.22M56.77M43.14M46.54M
Investing Cash Flow-57.55M-49.69M-99.67M-79.62M-72.89M-56.61M
Financing Cash Flow10.93M-1.43M30.50M13.94M-6.21M64.44M

Calian Group Technical Analysis

Technical Analysis Sentiment
Positive
Last Price77.24
Price Trends
50DMA
69.11
Positive
100DMA
61.01
Positive
200DMA
54.85
Positive
Market Momentum
MACD
3.26
Positive
RSI
58.37
Neutral
STOCH
23.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CGY, the sentiment is Positive. The current price of 77.24 is below the 20-day moving average (MA) of 79.40, above the 50-day MA of 69.11, and above the 200-day MA of 54.85, indicating a neutral trend. The MACD of 3.26 indicates Positive momentum. The RSI at 58.37 is Neutral, neither overbought nor oversold. The STOCH value of 23.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CGY.

Calian Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
C$446.62M12.988.31%3.43%26.29%-6.47%
67
Neutral
C$1.95B16.268.95%8.32%-2.45%44.20%
66
Neutral
C$882.26M30.996.36%1.98%3.69%92.38%
64
Neutral
C$743.96M17.9414.45%3.02%-0.73%221.74%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
55
Neutral
C$81.95M9.7926.87%5.99%-7.01%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CGY
Calian Group
79.19
37.78
91.23%
TSE:DCM
Data Commun Management
1.48
-0.29
-16.38%
TSE:DXT
Dexterra Group
12.01
4.65
63.09%
TSE:KBL
K-Bro Linen
35.23
3.90
12.45%
TSE:TCL.A
Transcontinental
23.44
6.58
38.99%

Calian Group Corporate Events

Business Operations and Strategy
Calian, ADGA Team Up on Next-Gen Land Training for Canadian Army
Positive
Feb 26, 2026

Calian Group and ADGA Group Consultants have signed a three-year collaboration agreement to develop next-generation integrated land training and simulation capabilities for the Canadian Army. The partnership aligns their complementary strengths in advanced training, secure systems and operational engineering to address the Canadian Army’s growing need for realistic, digitally enabled training that reflects modern, multi-domain warfare.

The collaboration directly supports Canada’s Defence Industrial Strategy by bolstering sovereign land capability and delivering scalable, interoperable training architectures tied to operational C5ISRT networks. By focusing on synthetic environments, system-agnostic platforms and secure digital infrastructure, the deal is expected to enhance the Army’s ability to “train as it will fight,” improving readiness, resilience and long-term sustainment while reinforcing both firms’ positions in Canada’s defence training ecosystem.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$81.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and Strategy
Calian and ADGA Join Forces on Next-Generation Land Training for Canadian Army
Positive
Feb 26, 2026

Calian Group and ADGA Group have signed a three-year collaboration agreement to jointly develop next-generation integrated land training and simulation capabilities for the Canadian Army. The partnership aligns their complementary strengths in advanced training, secure digital systems and operational engineering to better address the complexities of modern, multi-domain warfare.

The companies plan to build scalable, system-agnostic synthetic training environments that tightly connect C5ISRT architectures to operational networks, enabling soldiers to train in the same digital conditions they face in theatre. By supporting Canada’s Defence Industrial Strategy and emphasizing secure-by-design infrastructure and cyber resilience, the initiative aims to enhance the Canadian Army’s readiness and sustainment while reinforcing Canada’s sovereign land training capability.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$81.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Calian Names Veteran Finance Executive Will Majic Acting CFO to Support Next Growth Phase
Positive
Feb 24, 2026

Calian Group has named longtime finance executive Will Majic as acting chief financial officer, elevating him from his role as vice president of finance. A chartered professional accountant who joined Calian in 2017, Majic has helped steer the company’s rapid expansion, including revenue growth from about $275 million to more than $750 million and the execution of 19 acquisitions.

During his tenure, Majic has also supported equity financings totaling $150 million, established a $350 million syndicated credit facility and led an enterprise-wide ERP rollout that strengthened controls and reporting. His appointment signals continuity in Calian’s financial strategy as it pursues further growth in mission-critical markets, reinforcing its capital discipline and operational infrastructure for the next phase of expansion.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$81.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Calian Shareholders Re-Elect Board, Name Valerie Sorbie as Chair
Positive
Feb 12, 2026

Calian shareholders overwhelmingly re-elected the company’s slate of director nominees at the February 12 annual meeting in Ottawa, with each candidate receiving approximately 98% or more of votes cast in favour. Following the vote, the board appointed director Valerie Sorbie as chair, a move that underscores continuity in governance while positioning Calian’s leadership to support its ongoing growth in mission-critical solutions across global markets.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$74.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
Calian Delivers Record Q1 Revenue and Margin Gains as Defence Demand Builds
Positive
Feb 12, 2026

Calian opened fiscal 2026 with record first-quarter revenue of $208 million, up 12% year over year, driven evenly by 6% organic growth and 6% from recent acquisitions including Advanced Medical Solutions and InField Scientific. Strong demand in Defence & Space and higher-margin product mix lifted gross margin to 34.1% and boosted adjusted EBITDA by 28% to $23 million, while net profit swung to $5.1 million from a loss a year earlier.

Operating free cash flow rose to $16 million, supporting $18 million in acquisition spending, $2 million in capex and $3 million in dividends, leaving net debt at 1.2 times adjusted EBITDA and maintaining balance sheet flexibility. With $171 million in new contract signings, a $1.4 billion backlog and a new initiative to accelerate Canadian C5ISRT defence capabilities through its Calian VENTURES arm, the company signaled continued growth ambitions and a strengthening position in defence and critical infrastructure markets.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$74.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
Calian Delivers Record Q1 Revenue and Margin Gains as Defence and Space Drive Growth
Positive
Feb 12, 2026

Calian Group opened fiscal 2026 with record quarterly revenue of $208 million, up 12% year over year, driven equally by 6% organic growth and 6% from acquisitions such as Advanced Medical Solutions and InField Scientific. Strength in Defence & Space and Essential Industries, alongside a richer product mix, lifted gross margin to 34.1% and pushed adjusted EBITDA up 28% to $23 million, expanding margins and turning last year’s net loss into a $5.1 million profit.

Operating free cash flow rose to $15.8 million, enabling $2 million in capex, $18 million for acquisitions and earnouts, and $3 million in dividends, while keeping net debt to adjusted EBITDA at 1.2x and preserving balance-sheet flexibility. With $171 million in new contract signings, a $1.4 billion backlog and a new initiative via Calian Ventures to accelerate Canadian C5ISRT defence capabilities, the company is reinforcing its position in defence and space and signaling continued investment-led growth for shareholders and domestic defence stakeholders.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$74.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and Strategy
Calian’s SatService Wins German Defence Deal for Advanced Q/V-Band SATCOM Station
Positive
Feb 10, 2026

SatService GmbH, a Calian subsidiary and European satellite ground systems provider, has secured a contract from Germany’s Federal Ministry of Defence, represented by the Bundeswehr University Munich, to supply a full-service Q/V-band satellite ground station. The system will feature a high-performance 4-metre antenna operating in the Q/V-band for geostationary orbit applications, a capability not currently available at the university.

The new ground station will support scientific research and modern military SATCOM, giving trainee officers secure, high-throughput satellite connectivity and hands-on exposure to geostationary operations and their benefits. The project underscores Germany and the EU’s broader investment in sovereign satellite communications across multiple frequency bands, reinforcing Calian’s and SatService’s positioning as key technology partners in advanced, secure SATCOM infrastructure for defence and research stakeholders.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$74.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Financial Disclosures
Calian Sets Feb. 12 Conference Call to Discuss Q1 FY2026 Results
Neutral
Jan 29, 2026

Calian Group Ltd. will release its financial results for the first quarter of fiscal 2026, covering the period ended December 30, 2025, before markets open on February 12, 2026, followed by an 8:30 a.m. Eastern Time conference call for analysts and media via webcast on the company’s investor website. The event, which will include a replay accessible online shortly after the call, underscores Calian’s ongoing engagement with the financial community and provides stakeholders with an opportunity to assess the company’s performance and outlook in its key defence, space, healthcare and critical infrastructure markets.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$92.50 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Calian Deploys $100 Million to Build National C5ISRT Defence Innovation Network
Positive
Jan 26, 2026

Calian Group, through its Calian VENTURES arm, is mobilizing an initial $100 million from multiple funding sources to accelerate the development and deployment of sovereign Canadian C5ISRT (Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance, Reconnaissance and Targeting) capabilities. The initiative will establish a national network of regional development labs that bring together SMEs, the Canadian Armed Forces, NATO, government, academia and industry partners to test, validate and scale interoperable defence technologies, with the goal of strengthening Arctic sovereignty, enhancing national security and modernizing the Canadian Armed Forces. By providing shared infrastructure, technical expertise and integration pathways, Calian aims to position itself as a central orchestrator of Canada’s defence innovation ecosystem and to help build the Canadian defence industrial base while ensuring sovereign control over critical defence data and systems.

The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$65.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026